Dan LeBatard offers the most intelligent and mature take on PEDs in sports I’ve seen in ages. He asks us to take a step back and ask ourselves why it is we are so hung up on a certain, narrow kind of performance enhancement in sports when we never question it — indeed, we openly praise it — when athletes do insane things to their bodies, all in the name of staying on the field? Often things that could cause massive harm.
Stuff like Ronnie Lott cutting his finger off. Lomas Brown playing with a catheter. Players having ligaments taken from cadavers and inserted into their own bodies. Drug therapies and medical procedures that are wholly unnecessary for a normal quality of life but are accepted in the name of athletic performance. We are totally fine with these. We are not totally fine with others:
We are OK with Kirk Gibson hitting one of the most famous home runs ever on one steroid (cortisone), but we slam the Hall of Fame door on the face of everybody else who might have used the anabolic kind. Granted, cortisone is not a banned performance enhancer, but it certainly enhanced Gibson’s performance, which wouldn’t have been possible without it. Lost in the shouting of “Cheater!” and “Fraud!” from a pill-popping America is how often athletes have to go through the pharmacy for the healing properties of hormones — not just to hit home runs but because what they do for a daily living really hurts.
It is not enough to draw some line and say “well, [drug/procedure X] is banned and [drug/procedure Y] is not banned.” It makes people who like to pour crap on banned PED users feel better, but it’s a most pedantic distinction. Why are some procedures and drugs banned and others not? Why do we allow some sorts of performance enhancement or enabling but not others? If it’s OK for Kirk Gibson to take a drug that allowed him to take the field when he otherwise could not have, why do we not allow other players to take other drugs that allow them to take the field when they otherwise can’t?
More broadly, as fans and observers, why do we seem to care so much and get so annoyed at certain sorts of seemingly unnatural acts undertaken by athletes but don’t care a bit — or, alternatively, fully expect — so many others?
Cubs outfielder Jason Heyward hasn’t played since Sunday due to a sore right wrist, but he’s hoping to be included in his team’s lineup on Friday, MLB.com’s Carrie Muskat reports. Matt Szucur, Ben Zobrist, and Kris Bryant have handled right field while Heyward has been out.
Heyward, 26, has gotten off to a disappointing start, as he’s batting .211/.317/.256 with only four doubles, no home runs, and 13 RBI in 104 plate appearances. He signed an eight-year, $184 million contract with the Cubs back in December.
Heyward said he hurt his wrist putting emphasis on it during hitting drills. He said, “I was doing some work off the tee and doing a drill with a donut on the bat, swinging, trying to stay through the middle, and I put more emphasis on [his wrist] and strained it from that.”
Cardinals shortstop Jhonny Peralta is expected to return from the disabled list in early June, which means current shortstop Aledmys Diaz would return to the bench. There’s only one problem: Diaz has been one of the best hitters in baseball. The 25-year-old owns a sparkling .381/.422/.679 triple-slash line with 14 extra-base hits (including five homers) in 90 plate appearances.
The Cardinals plan to get creative to keep Diaz’s bat in the lineup. Per Jon Morosi of FOX Sports, the club is considering using Peralta at first and third base. Peralta, 33, last played third base in 2010 with the Indians and Tigers. He has logged only three games and nine total defensive innings at first base in his major league career.
Diaz isn’t about to displace Peralta. Last season, Peralta was one of the best-hitting shortstops, finishing with a .275/.334/.411 triple-slash line with 17 home runs and 41 RBI in 640 plate appearances. He was even more productive in 2014, his first year with the Cardinals.
Athletics pitcher Chris Bassitt will undergo season-ending Tommy John surgery on Friday, MLB.com’s Jane Lee reports. He was diagnosed with a partially torn ulnar collateral ligament over the weekend, so this news doesn’t come as much of a surprise.
Bassitt, 27, is certainly out for the remainder of the 2016 season and will likely miss a sizable portion of the 2017 season as well. The right-hander made five starts for the A’s to begin the season, but put up an ugly 6.11 ERA with a 23/14 K/BB ratio in 28 innings.
Jesse Hahn took Bassitt’s spot in the Athletics’ starting rotation. Hahn is expected to start next on Saturday versus the Orioles.
Mike Berardino of the St. Paul Pioneer press is reporting that the Twins have placed pitchers Tommy Milone and Casey Fien on waivers. Berardino adds that Fien would be able to reject a demotion to the minors if he passes through waivers, but Milone could not. Milone and Fien are only a part of what’s been ailing the 8-20 Twins.
Milone, 29, was solid out of the rotation for the Twins last season, but the same can’t be said of his start to the 2016 season. The lefty has a 5.79 ERA with a 19/7 K/BB ratio over four starts and one relief appearance. He was taken out of the Twins’ rotation following his final start in April.
Fien, 32, was also dependable for the Twins in previous years, but has had a rocky 2016 thus far. The right-hander has yielded 12 runs on 21 hits and three walks with 12 strikeouts in 13 2/3 innings.
Milone will be eligible for his third and final year of arbitration after the season after earning $4.5 million this season. Fien has two more years of arbitration eligibility left — his third and fourth — and is earning $2.275 million this year.